Gene delivery strategies targeting stable atheromatous plaque.
Conventional therapeutic options to treat chronic angina pectoris are pharmacological interventions, coronary bypass surgery (CABG) and percutaneous coronary intervention (PCI). In animal models, it was shown that gene delivery strategies harbour an exciting potential to support and maybe even repla...
Principais autores: | Van-Assche, T, Huygelen, V, Crabtree, M, Antoniades, C |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2013
|
Registros relacionados
-
Gene therapy targeting inflammation in atherosclerosis.
por: Van-Assche, T, et al.
Publicado em: (2011) -
Targeting vascular redox biology through antioxidant gene delivery: a historical view and current perspectives.
por: Van Assche, T, et al.
Publicado em: (2011) -
Periodontal pathogens in atheromatous plaque
por: Saroj K. Rath, et al.
Publicado em: (2014-01-01) -
Macrophages in Atheromatous Plaque Developmental Stages
por: Alexander von Ehr, et al.
Publicado em: (2022-04-01) -
Letter to the Editor. Atheromatous Plaque Vulnerability — the Neglected Vulnerable Carotid Plaques
por: Péter Levente
Publicado em: (2017-09-01)